These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 3009557

  • 1. Immunohistochemical detection of ras oncogene p21 product in benign and malignant mammary tissue in man.
    Ghosh AK, Moore M, Harris M.
    J Clin Pathol; 1986 Apr; 39(4):428-34. PubMed ID: 3009557
    [Abstract] [Full Text] [Related]

  • 2. Immunocytochemical demonstration and significance of p21 ras family oncogene product in benign and malignant breast disease.
    Candlish W, Kerr IB, Simpson HW.
    J Pathol; 1986 Nov; 150(3):163-7. PubMed ID: 3027290
    [Abstract] [Full Text] [Related]

  • 3. Expression of ras oncogene p21 protein in relation to regional spread of human breast carcinomas.
    Czerniak B, Chen R, Tuziak T, Markiewski M, Kram A, Gorczyca W, Deitch D, Herz F, Koss LG.
    Cancer; 1989 May 15; 63(10):2008-13. PubMed ID: 2467732
    [Abstract] [Full Text] [Related]

  • 4. Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues.
    Ohuchi N, Thor A, Page DL, Hand PH, Halter SA, Schlom J.
    Cancer Res; 1986 May 15; 46(5):2511-9. PubMed ID: 3084069
    [Abstract] [Full Text] [Related]

  • 5. Immunohistochemical study of the ras oncogene expression in human breast lesions.
    Agnantis NJ, Petraki C, Markoulatos P, Spandidos DA.
    Anticancer Res; 1986 May 15; 6(5):1157-60. PubMed ID: 3541779
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical demonstration of ras p21 oncogene product in normal, benign, and malignant human thyroid tissues.
    Mizukami Y, Nonomura A, Hashimoto T, Terahata S, Matsubara F, Michigishi T, Noguchi M.
    Cancer; 1988 Mar 01; 61(5):873-80. PubMed ID: 3276392
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Elevated ras oncogene expression correlates with lymph node metastases in breast cancer patients.
    Lundy J, Grimson R, Mishriki Y, Chao S, Oravez S, Fromowitz F, Viola MV.
    J Clin Oncol; 1986 Sep 01; 4(9):1321-5. PubMed ID: 3528401
    [Abstract] [Full Text] [Related]

  • 11. Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues.
    Sappino AP, Skalli O, Jackson B, Schürch W, Gabbiani G.
    Int J Cancer; 1988 May 15; 41(5):707-12. PubMed ID: 2835323
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunoprecipitation of cell lysates with RAP-5 does not specifically detect ras oncogene product p21.
    Gutheil JC, Mane S, Kapil V, Needleman SW.
    Hum Pathol; 1989 Dec 15; 20(12):1176-80. PubMed ID: 2687155
    [Abstract] [Full Text] [Related]

  • 14. Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas.
    Hand PH, Vilasi V, Thor A, Ohuchi N, Schlom J.
    J Natl Cancer Inst; 1987 Jul 15; 79(1):59-65. PubMed ID: 3298786
    [Abstract] [Full Text] [Related]

  • 15. Expression of ras oncogene p21 during human fetal development as determined by monoclonal antibodies RAP-5, Y13-259, and DWP.
    Radosevich JA, Combs SG, Ma Y, Lee I, Gould VE, Thor A, Schlom J, Carney WP, Rosen ST.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1989 Jul 15; 56(5):337-44. PubMed ID: 2565631
    [Abstract] [Full Text] [Related]

  • 16. Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization.
    Ohuchi N, Hand PH, Merlo G, Fujita J, Mariani-Costantini R, Thor A, Nose M, Callahan R, Schlom J.
    Cancer Res; 1987 Mar 01; 47(5):1413-20. PubMed ID: 2434216
    [Abstract] [Full Text] [Related]

  • 17. [Immunohistochemical study of ras p21 expression in human gastric cancers and benign lesions].
    Nakajima K.
    Hokkaido Igaku Zasshi; 1987 Jul 01; 62(4):573-80. PubMed ID: 3315926
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.